Amicus Therapeutics Inc (FOLD) Q3 2024 Earnings Call Highlights: Strong Revenue...

Published on 7 Nov 2024 on GuruFocus.com · via Yahoo Finance

Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to...

Read the rest of the article

Start tracking your investments with Statfolio

On November 6, Campbell sold 7,901 shares of common stock at an average price of $12.5048, totali...

Investing.com 8 Nov 2024

Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

Amicus Therapeutics (NASDAQ: NASDAQ:FOLD) has reported a significant increase in revenue for the...

Investing.com 6 Nov 2024

Total Revenue: $127 million, a 34% increase year-over-year, or 36% on a constant currency basis....

GuruFocus.com · via Yahoo Finance 11 Oct 2024

We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have ...

Insider Monkey · via Yahoo Finance 24 Sep 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript May 9, 2024 Amicus Thera...

Insider Monkey via Yahoo Finance 8 May 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is possibly approaching a major achievement in its busine...

Simply Wall St. via Yahoo Finance 19 Apr 2024

Director Margaret Mcglynn has sold 15,000 shares of Amicus Therapeutics Inc (NASDAQ:FOLD) on Marc...

GuruFocus.com via Yahoo Finance 7 Mar 2024

Last week saw the newest full-year earnings release from Amicus Therapeutics, Inc. (NASDAQ:FOLD),...

Simply Wall St. via Yahoo Finance 2 Mar 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript February 28, 2024 Amicus...

Insider Monkey via Yahoo Finance 29 Feb 2024